The Meza lab focuses on the assessment of cancer and tobacco prevention and control strategies. We focus on lung cancer, tobacco-related cancers, HPV-related cancers.
Dr. Rafael Meza, PhD
Impact of Joint Lung Cancer Screening and Cessation Interventions Under the New Recommendations of the U.S. Preventive Services Task Force.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer, 2022
Cost-effectiveness Evaluation of the 2021 US Preventive Services Task Force Recommendation for Lung Cancer Screening.
JAMA oncology, 2021
Estimated Prevalence of Smoking and Smoking-Attributable Mortality Associated With Graphic Health Warnings on Cigarette Packages in the US From 2022 to 2100.
JAMA health forum, 2021
Public health impact of a US ban on menthol in cigarettes and cigars: a simulation study.
Tobacco control, 2021
Evaluation of the Benefits and Harms of Lung Cancer Screening With Low-Dose Computed Tomography: Modeling Study for the US Preventive Services Task Force.
Transitions between cigarette, ENDS and dual use in adults in the PATH study (waves 1-4): multistate transition modelling accounting for complex survey design.
Tobacco control, 2020
BC Cancer Foundation is the fundraising partner of BC Cancer, which includes BC Cancer Research. Together with our donors, we are changing cancer outcomes for British Columbians by funding innovative research and personalized treatment and care.